Sophia Bioscience, Inc.
Marietta, GA
- UEI
- HEPWWVBLM4C5
- CAGE
- 6TB87
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 737 Robinson Farms Dr, Marietta, GA 30068, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of novel targeted therapy for hepatocellular carcinoma | National Cancer Institute (NIH) | $300,000 | |
| Development of novel targeted therapy for prostate cancer | National Institutes of Health | $224,996 |
Quick answers
Is Sophia Bioscience, Inc. registered in SAM.gov?
Yes. Sophia Bioscience, Inc.'s SAM.gov registration is active through December 22, 2026.
What is Sophia Bioscience, Inc.'s most recent federal award?
Sophia Bioscience, Inc.'s most recent federal grant award is Development of novel targeted therapy for hepatocellular carcinoma (R43CA224642), from National Cancer Institute (NIH), on September 20, 2018.
On GovTribe
See Sophia Bioscience, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors